EA
eat_dis_watermelon
eat_dis_watermelon
Community Contributor
Followers0Total number of followers
Comments0Total number of comments
Member Since2022Date joined

No bio added yet

No link added
LLY logo
Eli Lilly

Eli Lilly's Future Growth Driven by Tirzepatide and Favorable Market Conditions

Catalysts Mounjaro/Zepbound: Lilly’s tirzepatide franchise is the engine of growth. Mounjaro (for type 2 diabetes) and Zepbound (obesity) each grew rapidly in 2024.
View narrative
US$1.19k
FV
35.8% undervalued intrinsic discount
20.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
New narrative